Abbott Laboratories continued to struggle in the fourth quarter with challenges in overseas markets, including the continued fallout from a recall that has damaged Abbott's baby-formula products in Asia and a weakened European economy that pressured sales of generic drugs.

Abbott, which also makes medical devices and diagnostics, said sales rose 0.4% to $5.65 billion in the quarter from $5.63 billion in the year-earlier quarter. Net profit fell 44% to $589 million, or 37 cents a share, from $1.05 billion, or 66 cents a...